{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:12:34Z","timestamp":1780366354926,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ajoc.2022.101686","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T02:40:49Z","timestamp":1661481649000},"page":"101686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bilateral corneal perforation in Ipilimumab\/Nivolumab - associated peripheral ulcerative keratitis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-8345","authenticated-orcid":false,"given":"Julia","family":"Aschauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3008-8192","authenticated-orcid":false,"given":"Ruth","family":"Donner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-5317","authenticated-orcid":false,"given":"Jan","family":"Lammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-7030","authenticated-orcid":false,"given":"Gerald","family":"Schmidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajoc.2022.101686_bib1","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00262-020-02635-3","article-title":"Factors associated with ocular adverse event after immune checkpoint inhibitor treatment","volume":"69","author":"Kim","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101686_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101686_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","article-title":"Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review","volume":"17","author":"Abdel-Rahman","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101686_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.survophthal.2021.02.013","article-title":"Peripheral ulcerative keratitis","volume":"66","author":"Gupta","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101686_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0161-6420(92)32006-8","article-title":"Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy","volume":"99","author":"Kervick","year":"1992","journal-title":"Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101686_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3747\/co.25.4235","article-title":"Immune-related adverse events of immune checkpoint inhibitors: a brief review","volume":"25","author":"Myers","year":"2018","journal-title":"Curr Oncol"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101686_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11864-018-0562-9","article-title":"Treatment of complications from immune checkpoint inhibition in patients with lung cancer","volume":"19","author":"Wills","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101686_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/imt-2018-0107","article-title":"First-line checkpoint inhibitors for wild-type advanced non-small-cell cancer: a pair-wise and network meta-analysis","volume":"11","author":"Wang","year":"2019","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101686_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCO.0000000000000296","article-title":"Ocular and orbital side-effects of checkpoint inhibitors: a review article","volume":"28","author":"Antoun","year":"2016","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101686_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00002371-200411000-00008","article-title":"Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis","volume":"27","author":"Robinson","year":"2004","journal-title":"J Immunother"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101686_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/art.39406","article-title":"Autoimmune arthropathy and uveitis as complications of programmed death 1 inhibitor treatment","volume":"68","author":"de Velasco","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajoc.2022.101686_bib12","article-title":"Ocular immune-related adverse events associated with immune checkpoint inhibitors in lung cancer","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101686_bib13","first-page":"140","article-title":"Ipilimumab-induced ocular and orbital inflammation--A case series and review of the literature","volume":"24","author":"Papavasileiou","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101686_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ICO.0000000000000724","article-title":"Cyclosporine for dry eye associated with nivolumab: a case progressing to corneal perforation","volume":"35","author":"Nguyen","year":"2016","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101686_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/ICO.0000000000002460","article-title":"Nivolumab-induced ulcerative keratitis-A case report","volume":"40","author":"Losonczy","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2022.101686_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajoc.2019.01.013","article-title":"Corneal ulceration associated with Nivolumab use","volume":"14","author":"Parker","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.ajoc.2022.101686_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2016.10.008","article-title":"Corneal graft rejection in a patient treated with nivolumab for primary lung cancer","volume":"102","author":"Le Fournis","year":"2016","journal-title":"Lung Cancer"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622004327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622004327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:01:07Z","timestamp":1762527667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622004327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":17,"alternative-id":["S2451993622004327"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101686","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilateral corneal perforation in Ipilimumab\/Nivolumab - associated peripheral ulcerative keratitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101686"}}